BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guzinska-Ustymowicz K, Kemona A. Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 2005; 11(8): 1193-1195 [PMID: 15754403 DOI: 10.3748/wjg.v11.i8.1193]
URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1193.htm
Number Citing Articles
1
Francesco Blasi, Chiara Bruckmann, Dmitry Penkov, Leila Dardaei. A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancerBioEssays 2017; 39(5) doi: 10.1002/bies.201600245
2
C. EVANS, A. G. DALGLEISH, D. KUMAR. Review article: immune suppression and colorectal cancerAlimentary Pharmacology & Therapeutics 2006; 24(8): 1163 doi: 10.1111/j.1365-2036.2006.03075.x
3
J Braun, C Hoang-Vu, H Dralle, S Hüttelmaier. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomasOncogene 2010; 29(29): 4237 doi: 10.1038/onc.2010.169
4
Friedrich Prall, Christiane Ostwald. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutationsHuman Pathology 2007; 38(11): 1696 doi: 10.1016/j.humpath.2007.04.002
5
Maya Gulubova, Irena Manolova, Julian Ananiev, Alexander Julianov, Yovcho Yovchev, Katya Peeva. Role of TGF-β1, its receptor TGFβRII, and Smad proteins in the progression of colorectal cancerInternational Journal of Colorectal Disease 2010; 25(5): 591 doi: 10.1007/s00384-010-0906-9
6
Rong Qiu, Jian Chen, Jun Sima, Xiangdi Shen, Dandan Liu, Jian Shen. NS398 induces apoptosis in non-small cell lung cancer cellsJournal of Cancer Research and Clinical Oncology 2012; 138(1): 119 doi: 10.1007/s00432-011-1080-3
7
Sonya Youngju Park, Jinyoung Yoo. Expression of Transforming Growth Factor β1 and Cadherins in Lung AdenocarcinomaJournal of Lung Cancer 2012; 11(1): 38 doi: 10.6058/jlc.2012.11.1.38
8
Yvonne M. Saenger, Robert R. Jenq, Miguel-Angel Perales. General Principles of Tumor Immunotherapy2007; : 67 doi: 10.1007/978-1-4020-6087-8_5
9
Maya Gulubova, Julian Ananiev, Yovchev Yovchev, Aleksander Julianov, Anatoli Karashmalakov, Tatyana Vlaykova. The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients’ survivalJournal of Molecular Histology 2013; 44(6): 679 doi: 10.1007/s10735-013-9520-9
10
Ali Flores-Pérez, Laurence A. Marchat, Sergio Rodríguez-Cuevas, Verónica Bautista-Piña, Alfredo Hidalgo-Miranda, Elena Aréchaga Ocampo, Mónica Sierra Martínez, Carlos Palma-Flores, Miguel A. Fonseca-Sánchez, Horacio Astudillo-de la Vega, Erika Ruíz-García, Juan Antonio González-Barrios, Carlos Pérez-Plasencia, María L. Streber, César López-Camarillo. Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancerScientific Reports 2016; 6(1) doi: 10.1038/srep34504
11
É. J. Ryan, B. Creavin, Y. L. Khaw, M. E. Kelly, H. M. Mohan, R. Geraghty, E. J. Ryan, R. Kennelly, A. Hanly, S. T. Martin, D. Fennelly, R. McDermott, D. Gibbons, P. R O'Connell, K. Sheahan, D. C. Winter. Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancerBJS Open 2018; 2(6): 456 doi: 10.1002/bjs5.91
12
Federica Ungaro, Silvia D’Alessio, Silvio Danese. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic StrategiesCancers 2020; 12(8): 2060 doi: 10.3390/cancers12082060
13
F Prall. Tumour budding in colorectal carcinomaHistopathology 2007; 50(1): 151 doi: 10.1111/j.1365-2559.2006.02551.x
14
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotargetOncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
15
M Mantur, J Snarska, O Koper, J Dziecioł, A Płonski, D Lemancewicz. Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients.Folia Histochemica et Cytobiologica 2010; 47(4) doi: 10.2478/v10042-009-0077-0
16
Wujin Chen, Yiyi Jin, Hong Yang, Lihui Wei, Jiumao Lin. Hedyotis diffusa Willd reduces migration and invasion through inhibition of TGF-β-induced EMT in colorectal cancer cellsEuropean Journal of Integrative Medicine 2018; 23: 57 doi: 10.1016/j.eujim.2018.09.008
17
Sean C. Glasgow, Joshua I.S. Bleier, Lawrence J. Burgart, Charles O. Finne, Ann C. Lowry. Meta-analysis of Histopathological Features of Primary Colorectal Cancers that Predict Lymph Node MetastasesJournal of Gastrointestinal Surgery 2012; 16(5): 1019 doi: 10.1007/s11605-012-1827-4
18
Hao Yu, Xing-Xiu Li, Xing Han, Bin-Xin Chen, Xing-Hua Zhang, Shan Gao, Dan-Qi Xu, Yao Wang, Zhan-Kui Gao, Lei Yu, Song-Ling Zhu, Li-Chen Yao, Gui-Rong Liu, Shu-Lin Liu, Xiao-Qin Mu. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responsesFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1126808
19
Miriam E. Uhlmann, Milka Georgieva, Martin Sill, Ulrich Linnemann, Martin R. Berger. Prognostic value of tumor progression-related gene expression in colorectal cancer patientsJournal of Cancer Research and Clinical Oncology 2012; 138(10): 1631 doi: 10.1007/s00432-012-1238-7
20
David Bacman, Susanne Merkel, Roland Croner, Thomas Papadopoulos, Wolfgang Brueckl, Arno Dimmler. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective studyBMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-156
21
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in colorectal cancer—ready for diagnostic practice?Human Pathology 2016; 47(1): 4 doi: 10.1016/j.humpath.2015.08.007